The Latest Breaking News from Eli Lilly

Exclusive: TikTok sellers purporting to sell the ‘Triple G’ of weight loss jabs have had their accounts pulled after The Independent exposed them to the social media giant

A federal appeals court has upheld a $183.7 million judgment against Eli Lilly and Co. (NYSE:LLY), rejecting the drugmaker's attempt to overturn a whistleblower lawsuit that accused it of defrauding Medicaid.

The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity drug market.

Novo Nordisk (NYSE:NVO) has announced a significant restructuring plan that will see the company cut 9,000 jobs, representing 11.5% of its workforce. The decision comes as the pharmaceutical giant faces mounting pressure from U.S. competitor Eli Lilly (NYSE:LLY).

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly

IN FULL

Eli Lilly’s new pill could offer an easier path to weight loss for needle-averse patients

The MP for Neath and Swansea East fears the drug’s price rise will exclude others from using Mounjaro

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

Doctors say NHS rollout not fit for purpose with fewer than half of commissioning bodies prescribing Mounjaro

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s (NYSE:LLY) olomorasib, in combination with Merck Co. Inc.’s (NYSE:MRK) anti-PD-1 therapy Keytruda (pembrolizumab), for the first-line treatment of unresectable advanced or metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation…